Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

NCT04981379 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

DRUG: Hydroxychloroquine
DRUG: Favipiravir
DRUG: Favipiravir + Hydroxychloroquine
DRUG: Placebo

Sponsor

Health Institutes of Turkey